🎉 M&A multiples are live!
Check it out!

Middle East Healthcare Valuation Multiples

Discover revenue and EBITDA valuation multiples for Middle East Healthcare and similar public comparables like Compass Pathways, Ramsay Health, and Integral Diagnostics.

Middle East Healthcare Overview

About Middle East Healthcare

Middle East Healthcare Co is a Saudi Arabia-based company engaged in the business of managing, operating and maintaining hospitals, medical centers, educational centers, rehabilitation centers, physiotherapy, laboratories and radiology centers, pharmacies, construction, and to buy land for the purpose of constructing medical projects and to establish, manage and organize exhibitions for the company.


Founded

2004

HQ

Saudi Arabia
Employees

n/a

Financials

LTM Revenue $794M

LTM EBITDA $181M

EV

$2.2B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Middle East Healthcare Financials

Middle East Healthcare has a last 12-month revenue of $794M and a last 12-month EBITDA of $181M.

In the most recent fiscal year, Middle East Healthcare achieved revenue of $769M and an EBITDA of $200M.

Middle East Healthcare expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Middle East Healthcare valuation multiples based on analyst estimates

Middle East Healthcare P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $708M $769M XXX XXX XXX
Gross Profit $181M $271M XXX XXX XXX
Gross Margin 26% 35% XXX XXX XXX
EBITDA $145M $200M XXX XXX XXX
EBITDA Margin 21% 26% XXX XXX XXX
Net Profit $20.1M $48.1M XXX XXX XXX
Net Margin 3% 6% XXX XXX XXX
Net Debt $575M $636M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Middle East Healthcare Stock Performance

As of April 15, 2025, Middle East Healthcare's stock price is SAR 65 (or $17).

Middle East Healthcare has current market cap of SAR 6.0B (or $1.6B), and EV of SAR 8.4B (or $2.2B).

See Middle East Healthcare trading valuation data

Middle East Healthcare Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$2.2B $1.6B XXX XXX XXX XXX $0.79

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Middle East Healthcare Valuation Multiples

As of April 15, 2025, Middle East Healthcare has market cap of $1.6B and EV of $2.2B.

Middle East Healthcare's trades at 2.8x LTM EV/Revenue multiple, and 12.4x LTM EBITDA.

Analysts estimate Middle East Healthcare's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Middle East Healthcare and 10K+ public comps

Middle East Healthcare Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $2.2B XXX XXX XXX
EV/Revenue 2.9x XXX XXX XXX
EV/EBITDA 11.3x XXX XXX XXX
P/E 21.3x XXX XXX XXX
P/E/Growth 2.1x XXX XXX XXX
EV/FCF 29.4x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Middle East Healthcare Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Middle East Healthcare Valuation Multiples

Middle East Healthcare's NTM/LTM revenue growth is 11%

Middle East Healthcare's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.

Over next 12 months, Middle East Healthcare's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Middle East Healthcare's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Middle East Healthcare and other 10K+ public comps

Middle East Healthcare Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 9% XXX XXX XXX XXX
EBITDA Margin 26% XXX XXX XXX XXX
EBITDA Growth 37% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 37% XXX XXX XXX XXX
Revenue per Employee n/a XXX XXX XXX XXX
Opex per Employee n/a XXX XXX XXX XXX
S&M Expenses to Revenue 3% XXX XXX XXX XXX
G&A Expenses to Revenue 5% XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue 23% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Middle East Healthcare Public Comps

See public comps and valuation multiples for Hospitals & Clinics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Burjeel Holdings XXX XXX XXX XXX XXX XXX
PureHealth XXX XXX XXX XXX XXX XXX
Integral Diagnostics XXX XXX XXX XXX XXX XXX
Ramsay Health XXX XXX XXX XXX XXX XXX
Compass Pathways XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Middle East Healthcare M&A and Investment Activity

Middle East Healthcare acquired  XXX companies to date.

Last acquisition by Middle East Healthcare was  XXXXXXXX, XXXXX XXXXX XXXXXX . Middle East Healthcare acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Middle East Healthcare

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Middle East Healthcare

When was Middle East Healthcare founded? Middle East Healthcare was founded in 2004.
Where is Middle East Healthcare headquartered? Middle East Healthcare is headquartered in Saudi Arabia.
Is Middle East Healthcare publicy listed? Yes, Middle East Healthcare is a public company listed on SAU.
What is the stock symbol of Middle East Healthcare? Middle East Healthcare trades under 4009 ticker.
When did Middle East Healthcare go public? Middle East Healthcare went public in 2016.
Who are competitors of Middle East Healthcare? Similar companies to Middle East Healthcare include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health.
What is the current market cap of Middle East Healthcare? Middle East Healthcare's current market cap is $1.6B
What is the current revenue of Middle East Healthcare? Middle East Healthcare's last 12-month revenue is $794M.
What is the current EBITDA of Middle East Healthcare? Middle East Healthcare's last 12-month EBITDA is $181M.
What is the current EV/Revenue multiple of Middle East Healthcare? Current revenue multiple of Middle East Healthcare is 2.8x.
What is the current EV/EBITDA multiple of Middle East Healthcare? Current EBITDA multiple of Middle East Healthcare is 12.4x.
What is the current revenue growth of Middle East Healthcare? Middle East Healthcare revenue growth between 2023 and 2024 was 9%.
Is Middle East Healthcare profitable? Yes, Middle East Healthcare is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.